يعرض 1 - 7 نتائج من 7 نتيجة بحث عن '"Robak, Pawel J."', وقت الاستعلام: 0.39s تنقيح النتائج
  1. 1
    Academic Journal
    Ixazomib plus daratumumab and dexamethasone: Final analysis of a phase 2 study among patients with relapsed/refractory multiple myeloma

    المؤلفون: Delimpasi, Sosana, Dimopoulos, Meletios A., Straub, Jan, Symeonidis, Argiris, Pour, Luděk, Hájek, Roman, Touzeau, Cyrille, Bhanderi, Viralkumar K., Berdeja, Jesus G., Pavlíček, Petr, Matous, Jeffrey V., Robak, Pawel J., Suryanarayan, Kaveri, Miller, Alison, Villarreal, Miguel, Cherepanov, Dasha, Srimani, Jaydeep K., Yao, Huilan, Labotka, Richard, Orlowski, Robert Z.

    المصدر: American Journal of Hematology ; volume 99, issue 9, page 1746-1756 ; ISSN 0361-8609 1096-8652

    الاتاحة: http://dx.doi.org/10.1002/ajh.27382
    https://onlinelibrary.wiley.com/doi/pdf/10.1002/ajh.27382

    View record in BASE

    أضف إلى المفضلة
  2. 2
    Periodical
    Efficacy and Safety of Oral Ixazomib (Ixa), Intravenous (IV) Daratumumab (Dara), and IV/Oral Dexamethasone (Dex; IDd) in Patients (Pts) with Relapsed/Refractory Multiple Myeloma (RRMM) and 1-3 Prior Therapies: Results of the Final Analysis of a Phase 2 Study

    المؤلفون: Delimpasi, Sosana, Dimopoulos, Meletios A., Straub, Jan, Symeonidis, Argiris, Hájek, Roman, Touzeau, Cyrille, Bhanderi, Viralkumar K., Berdeja, Jesus, Pavlíček, Petr, Matous, Jeffrey V., Robak, Pawel J., Suryanarayan, Kaveri, Villareal, Miguel, Cherepanov, Dasha, Srimani, Jaydeep K., Yao, Huilan, Labotka, Richard, Orlowski, Robert Z.

    المصدر: Blood; November 2022, Vol. 140 Issue: 1, Number 1 Supplement 1 p9995-9997, 3p

    Full Text Finder

    أضف إلى المفضلة
  3. 3
    Periodical
    Early Mortality in Patients with Multiple Myeloma Treated with Novel Agents - Analysis from Polish Myeloma Study Group

    المؤلفون: Charlinski, Grzegorz, Tyczyńska, Agata, Zaucha, Jan M, Czyz, Adriana, Czyż, Jarosław, Dytfeld, Dominik, Malecki, Bartosz, Gil, Lidia, Fornagiel, Szymon, Grosicki, Sebastian, Barchnicka, Agnieszka, Holojda, Jadwiga, Kolkowska, Agnieszka, Hus, Iwona, Helbig, Grzegorz, Kopinska, Anna, Masternak, Anna, Woszczyk, Dariusz, Markiewicz, Miroslaw, Piszcz, Jaroslaw, Kloczko, Janusz, Usnarska-Zubkiewicz, Lidia, Wrobel, Tomasz, Robak, Pawel J., Robak, Tadeusz, Waszczuk-Gajda, Anna, Basak, Grzegorz, Jurczyszyn, Artur

    المصدر: Blood; November 2020, Vol. 136 Issue: 1, Number 1 Supplement 1 p36-37, 2p

    Full Text Finder

    أضف إلى المفضلة
  4. 4
    Periodical
    Safety and Preliminary Efficacy Results from a Phase Ib/II Study of Cobimetinib As a Single Agent and in Combination with Venetoclax with or without Atezolizumab in Patients with Relapsed/Refractory Multiple Myeloma

    المؤلفون: Schjesvold, Fredrik, Ribrag, Vincent, Rodriguez-Otero, Paula, Robak, Pawel J., Hansson, Markus, Hajek, Roman, Amor, Adrián Alegre, Martinez-López, Joaquin, Onishi, Maika, Gallo, Jorge D., Raval, Aparna, Deshpande, Sameer, Malhi, Vikram, Hong, Wan-Jen, Raab, Marc S.

    المصدر: Blood; November 2020, Vol. 136 Issue: Supplement 1 p45-46, 2p

    Full Text Finder

    أضف إلى المفضلة
  5. 5
    Periodical
    OCEAN (OP-103): Melflufen/Dexamethasone Compared with Pomalidomide/Dexamethasone in Patients with Relapsed/Refractory Multiple Myeloma-Age Subgroup Analysis of Older Patients

    المؤلفون: Mateos, Maria-Victoria, Robak, Pawel J., Rosiñol, Laura, Symeonidis, Argiris, Sonneveld, Pieter, Thuresson, Marcus, Byrne, Catriona, Harmenberg, Johan, Hájek, Roman

    المصدر: Blood; November 2021, Vol. 138 Issue: 1, Number 1 Supplement 1 p2741-2741, 1p

    Full Text Finder

    أضف إلى المفضلة
  6. 6
    Periodical
    OCEAN (OP-103): Melflufen/Dexamethasone (Dex) Compared with Pomalidomide (Pom)/Dex in Patients (Pts) with Relapsed/Refractory Multiple Myeloma (RRMM) - Subgroup Analysis By Prior Alkylator Exposed/Refractory Status

    المؤلفون: Sonneveld, Pieter, Mateos, Maria-Victoria, Robak, Pawel J., Schjesvold, Fredrik H., Hajek, Roman, Richardson, Paul G., Harmenberg, Johan, Thuresson, Marcus, Byrne, Catriona, Dimopoulos, Meletios-Athanasios

    المصدر: Blood; November 2021, Vol. 138 Issue: 1, Number 1 Supplement 1 p4779-4779, 1p

    Full Text Finder

    أضف إلى المفضلة
  7. 7
    Periodical
    OCEAN (OP-103): Melflufen Plus Dexamethasone (Dex) Versus Pomalidomide (Pom) and Dex in Relapsed/Refractory Multiple Myeloma (RRMM) - Impact of Prior Treatments Analysis

    المؤلفون: Dimopoulos, Meletios-Athanasios, Schjesvold, Fredrik H., Mateos, María-Victoria, Robak, Pawel J., Hájek, Roman, Richardson, Paul G., Lindberg, Jakob, Thuresson, Marcus, Larsson, Kajsa, Sonneveld, Pieter

    المصدر: Blood; November 2021, Vol. 138 Issue: 1, Number 1 Supplement 1 p4780-4780, 1p

    Full Text Finder

    أضف إلى المفضلة
أدوات البحث: أحصل على تغذية RSS – أرسل هذا البحث بالبريد الإلكتروني – حفظ البحث – جدول التنبيهات: لا شيء